Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Therapeutics

SpliceBio

Miquel Vila-Perello

Sílvia Frutos

Neus Carne

Julian Esteve-Rudd

Gerard Caelles

SpliceBio

Org chart

Similar companies